These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8405057)
1. Ligation of CD28 receptor by B7 induces formation of D-3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation. Ward SG; Westwick J; Hall ND; Sansom DM Eur J Immunol; 1993 Oct; 23(10):2572-7. PubMed ID: 8405057 [TBL] [Abstract][Full Text] [Related]
2. Antibody ligation of CD7 leads to association with phosphoinositide 3-kinase and phosphatidylinositol 3,4,5-trisphosphate formation in T lymphocytes. Ward SG; Parry R; LeFeuvre C; Sansom DM; Westwick J; Lazarovits AI Eur J Immunol; 1995 Feb; 25(2):502-7. PubMed ID: 7533088 [TBL] [Abstract][Full Text] [Related]
3. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production. Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081 [TBL] [Abstract][Full Text] [Related]
4. Regulation of D-3 phosphoinositides during T cell activation via the T cell antigen receptor/CD3 complex and CD2 antigens. Ward SG; Ley SC; MacPhee C; Cantrell DA Eur J Immunol; 1992 Jan; 22(1):45-9. PubMed ID: 1346114 [TBL] [Abstract][Full Text] [Related]
5. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells. Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526 [TBL] [Abstract][Full Text] [Related]
6. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation. Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471 [TBL] [Abstract][Full Text] [Related]
7. Helper effector function of human T cells stimulated by anti-CD3 mAb can be enhanced by co-stimulatory signals and is partially dependent on CD40-CD40 ligand interaction. Kwekkeboom J; de Rijk D; Kasran A; Barcy S; de Groot C; de Boer M Eur J Immunol; 1994 Mar; 24(3):508-17. PubMed ID: 7510232 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Ward SG; Wilson A; Turner L; Westwick J; Sansom DM Eur J Immunol; 1995 Feb; 25(2):526-32. PubMed ID: 7875215 [TBL] [Abstract][Full Text] [Related]
9. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling. Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233 [TBL] [Abstract][Full Text] [Related]
10. Interaction of CD4:lck with the T cell receptor/CD3 complex induces early signaling events in the absence of CD45 tyrosine phosphatase. Deans JP; Kanner SB; Torres RM; Ledbetter JA Eur J Immunol; 1992 Mar; 22(3):661-8. PubMed ID: 1532148 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624 [TBL] [Abstract][Full Text] [Related]
12. B7 costimulates proliferation of CD4-8+ T lymphocytes but is not required for the deletion of immature CD4+8+ thymocytes. Tan R; Teh SJ; Ledbetter JA; Linsley PS; Teh HS J Immunol; 1992 Nov; 149(10):3217-24. PubMed ID: 1385518 [TBL] [Abstract][Full Text] [Related]
13. Rapid activation of C-Raf-1 after stimulation of the T-cell receptor or the muscarinic receptor type 1 in resting T cells. Siegel JN; June CH; Yamada H; Rapp UR; Samelson LE J Immunol; 1993 Oct; 151(8):4116-27. PubMed ID: 8409389 [TBL] [Abstract][Full Text] [Related]
15. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804 [TBL] [Abstract][Full Text] [Related]
16. MRC OX-2 defines a novel T cell costimulatory pathway. Borriello F; Lederer J; Scott S; Sharpe AH J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466 [TBL] [Abstract][Full Text] [Related]
17. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis. Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755 [TBL] [Abstract][Full Text] [Related]
18. CD28-dependent killing by human YT cells requires phosphatidylinositol 3-kinase activation. Lu Y; Rodriguez R; Bjorndahl J; Phillips CA; Trevillyan JM Eur J Immunol; 1996 Jun; 26(6):1278-84. PubMed ID: 8647205 [TBL] [Abstract][Full Text] [Related]
19. Costimulation via vascular cell adhesion molecule-1 induces in T cells increased responsiveness to the CD28 counter-receptor B7. Damle NK; Klussman K; Leytze G; Ochs HD; Aruffo A; Linsley PS; Ledbetter JA Cell Immunol; 1993 Apr; 148(1):144-56. PubMed ID: 7684325 [TBL] [Abstract][Full Text] [Related]
20. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation. Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]